CLASS ACTION UPDATE for BYND, STEM and CRL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 1, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

BYND Shareholders Click Here: https://zlk.com/pslra-1/beyond-meat-lawsuit-submission-form?prid=40157&wire=1
STEM Shareholders Click Here: https://zlk.com/pslra-1/stem-lawsuit-loss-submission-form?prid=40157&wire=1
CRL Shareholders Click Here: https://zlk.com/pslra-1/charles-river-lawsuit-submission-form?prid=40157&wire=1

* ADDITIONAL INFORMATION BELOW *

Beyond Meat, Inc. (NASDAQ:BYND)

BYND Lawsuit on behalf of: investors who purchased May 5, 2020 - October 13, 2022
Lead Plaintiff Deadline : July 10, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/beyond-meat-lawsuit-submission-form?prid=40157&wire=1

According to the complaint, throughout the Class Period defendants made numerous materially false and misleading statements and omissions concerning the Company's ability to produce plant-based meats at scale. Specifically, defendants repeatedly assured investors that Beyond Meat conducted "extensive testing" to "ensure manufacturability" of its plant-based meat products at commercial scale, and touted the success of the Company's product tests with its large-scale partnerships as "very positive." Further, defendants blamed any delays in launching these large-scale partnerships on Covid-19.

Stem, Inc. f/k/a Star Peak Energy Transition Corp. (NYSE:STEM)

This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired Stem securities: (a) pursuant and/or traceable to certain documents issued in connection with the merger consummated on April 28, 2021, by and among the Company, STPK Merger Sub Corp., and Stem, Inc., a private Delaware corporation; and/or (b) between March 4, 2021, and February 16, 2023, both dates inclusive.
Lead Plaintiff Deadline : July 11, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/stem-lawsuit-loss-submission-form?prid=40157&wire=1

According to the filed complaint, (i) Legacy Stem suffered from material weaknesses in internal control over financial reporting related to accounting for the deferred cost of goods sold and inventory, certain revenue recognition calculations, and internal-use capitalized software calculations; (ii) the Company had overstated Legacy Stem's and its own post-Merger business and financial prospects; (iii) Stem's software revenue did not makeup 100% of the Company's services revenue; (iv) Stem had overstated the benefits expected to flow from its AP partnership; and (v) as a result, the offering documents and defendants public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

Charles River Laboratories International, Inc. (NYSE:CRL)

CRL Lawsuit on behalf of: investors who purchased May 5, 2020 - February 21, 2023
Lead Plaintiff Deadline : July 18, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/charles-river-lawsuit-submission-form?prid=40157&wire=1

According to the filed complaint, during the class period, Charles River Laboratories International, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. Department of Justice; (3) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.